Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financials, balance sheet (quarterly)

1,375 INR

6.1999

0.45%

Last update May 2, 3:29 PM IST

Market closed

Day range

1,375

1,359

1,397.19995

Previous close

1,381.19995

Open

1,381.19995

Access this stock data via API

Glenmark Pharmaceuticals Ltd.

1,375.00

6.20

0.45%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	152.4B	143.6B	200.1B	193.7B
Current assets	90.3B	74.3B	112.7B	107.3B
Cash	—	16.6B	—	11.6B
Cash equivalents	—	—	—	—
Cash and cash equivalents	18.2B	16.6B	11.2B	11.6B
Other short term investments	2.2B	121.3M	2.3B	140.9M
Accounts receivable	28.6B	18.6B	32.0B	36.7B
Other receivables	—	1.5B	—	841.0M
Inventory	28.4B	25.1B	26.5B	23.7B
Prepaid assets	—	5.7B	—	6.4B
Restricted cash	—	11.9M	—	11.0M
Assets held for sale	—	0	26.2B	23.0B
Hedging assets	—	—	—	—
Other current assets	12.9B	12.2B	14.4B	11.5B
Non current assets	62.0B	69.3B	87.4B	86.5B
Properties	31.6B	31.2B	31.0B	39.0B
Land and improvements	—	461.3M	—	423.5M
Machinery furniture equipment	—	32.8B	—	32.6B
Construction in progress	4.0B	4.5B	12.2B	10.9B
Leases	—	—	—	—
Accumulated depreciation	—	-24.9B	—	-22.6B
Goodwill	14.2B	14.0B	25.0B	24.9B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	12.8B	12.7B	23.6B	23.4B
Investments and advances	—	—	—	—
Other non current assets	1.1B	1.5B	2.0B	1.5B
Total liabilities	67.9B	65.1B	102.7B	95.3B
Current liabilities	61.8B	58.2B	58.4B	51.1B
Accounts payable	23.6B	25.4B	19.2B	20.0B
Accrued expenses	—	—	—	—
Short term debt	16.4B	10.8B	11.4B	5.8B
Deferred revenue	—	—	—	—
Tax payable	1.7B	2.9B	1.2B	985.0M
Pensions	—	—	—	—
Other current liabilities	2.6B	877.2M	3.2B	58.7M
Non current liabilities	6.1B	6.9B	44.3B	44.3B
Long term provisions	—	—	—	—
Long term debt	1.4B	1.5B	40.4B	40.3B
Provision for risks and charges	—	—	—	—
Deferred liabilities	7.9M	2.8M	4.5M	5.1M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	16.9M	13.6M	13.3M
Shareholders equity
Common stock	282.2M	282.2M	282.2M	282.2M
Retained earnings	—	78.7B	—	94.6B
Other shareholders equity	—	—	—	—
Total shareholders equity	84.5B	78.5B	97.4B	98.4B
Additional paid in capital	—	17.1B	—	17.1B
Treasury stock	—	—	—	—
Minority interest	-1.6M	-3.8M	4.1B	3.7B